In conclusion, this study revealed that SNRPB promoted HCC progression by modulating the FOXM1-CCNB1 axis and lipid metabolism, indicating its potential as a therapeutic target to augment chemotherapy sensitivity in HCC. Here, CCNB1 is linked to hepatocellular carcinoma.